SNES
Get informed when a big investor buys or sells
+ FollowUndervalued by 168.5% based on the discounted cash flow analysis.
| Market cap | $9.17 Million |
|---|---|
| Enterprise Value | $5.02 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.95 |
| Beta | 0.19 |
| Outstanding Shares | 5,263,717 |
| P/E Ratio | -1.34 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | 1.55 |
| Enterprise Value to Revenue | 2.25 |
| Enterprise Value to EBIT | -0.72 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.53 |
| Debt to Equity | 0.34 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
SenesTech is changing the model for pest management by targeting one of the root causes of the problem: reproduction. ContraPest® is an innovative technology with an approach that targets the reproductive capabilities of both sexes in r...